Implementing Precision Medicine in Community-Based Oncology Programs: Three Models

Journal of Oncology Practice
Laura A LevitRichard L Schilsky

Abstract

The use of precision medicine and the number of genomic-based treatments and immunotherapies is increasing. Nevertheless, oncology providers face challenges to implementing precision medicine, including in community practices, where most patients receive treatment. On January 31, 2018, ASCO hosted Precision Medicine: Expanding Opportunities, the inaugural event in ASCO's new State of Cancer Care in America (SOCCA) event series. This article draws from the inaugural SOCCA event and the experiences of the SOCCA event participants to summarize the opportunities and challenges of precision medicine, and to highlight three successful models of implementing precision oncology in large, multisite community practices or networks: (1) Intermountain Healthcare, (2) Levine Cancer Institute, Atrium Health, and (3) National Cancer Care Alliance. The experience of these practices suggests that practice innovations that offer clinical decision support through molecular tumor boards and clinical pathways, and administrative support for prior authorization and clinical trial matching are key to successful implementation of large-scale, community-based precision medicine programs.

References

Apr 17, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eliezer M Van AllenMia A Levy
Apr 17, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Levi A Garraway
Apr 20, 2013·Journal of Oncology Practice·Stacy W GrayJane C Weeks
Apr 2, 2014·Nature Reviews. Clinical Oncology·Richard L Schilsky
May 7, 2014·The Oncologist·Maria SchwaederleRazelle Kurzrock
May 28, 2015·The New England Journal of Medicine·J Larry Jameson, Dan L Longo
Jul 30, 2015·Journal of Oncology Practice·Teresa M WatersBarbara L McAneny
Apr 5, 2016·Journal of Health Communication·Nunzia Bettinsoli GiuseChristine M Lovly
May 12, 2016·Journal of Oncology Practice·Lauren P Wallner, Sarah T Hawley
Sep 8, 2016·Nature·Vinay Prasad
Jun 1, 2017·American Society of Clinical Oncology Educational Book·Lee SchwartzbergDeborah Schrag
Jun 1, 2017·American Society of Clinical Oncology Educational Book·Jennifer L ErsekEdward S Kim
Nov 22, 2017·The Oncologist·Emily J MarchianoAndrew G Shuman
Dec 20, 2017·Nature Reviews. Clinical Oncology·Jeffrey A MoscowRichard L Schilsky
Jan 5, 2018·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Alessandro R MarconTimothy Caulfield
Feb 8, 2018·Journal of Oncology Practice·Bobby DalyLinda D Bosserman
Jun 16, 2018·Journal of Oncology Practice·M Kelsey KirkwoodRichard L Schilsky
Sep 21, 2018·American Society of Clinical Oncology Educational Book·Subha MadhavanJames L Chen

❮ Previous
Next ❯

Citations

Nov 14, 2019·Annals of the New York Academy of Sciences·Carlos G MoscosoClifford J Steer
Oct 18, 2019·Expert Review of Anticancer Therapy·Bridgette SchroaderKasia Shields
Jan 27, 2020·Clinical Pharmacology and Therapeutics·Kelsey A Klute
Aug 22, 2020·Yearbook of Medical Informatics·Ashley C GriffinArlene E Chung
Feb 11, 2020·JCO Oncology Practice·Linda Bosserman
Aug 7, 2019·Journal of Oncology Practice·Suanna Steeby BruinoogeRichard L Schilsky
May 22, 2019·Journal of Oncology Practice·Ryan W HueyAnaeze C Offodile
Dec 24, 2019·Journal of the National Cancer Institute·Samuel U TakvorianLawrence N Shulman
Mar 19, 2020·Pharmacy : Journal of Pharmacy, Education and Practice·Farah RaheemPatrick J Kiel
May 22, 2019·Journal of Oncology Practice·Dan S Zuckerman
Jan 28, 2021·BMC Medical Education·Srikar ChamalaChristopher R Cogle
Nov 2, 2020·Life Sciences, Society and Policy·M Walid QoronflehSaid Ismail
Mar 7, 2021·Pharmaceuticals·Ottavia BernocchiDaniele Generali
Mar 9, 2021·Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society·Nora AlkhudairAhmed Al-Jedai
Feb 4, 2022·Molecular Diagnosis & Therapy·Doreen Z Mhandire, Andrew K L Goey

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of the Advanced Practitioner in Oncology
Anthony J Olszanski, Laura J Zitella
Quality Management in Health Care
Andrew J KnightonPeter Daneryd
The Cancer Journal From Scientific American
S A Rosenberg
Journal of Healthcare Management / American College of Healthcare Executives
Ann Scheck McAlearneyPaula H Song
© 2022 Meta ULC. All rights reserved